These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 18641090

  • 1. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.
    Manzano-Fernández S, Pastor FJ, Marín F, Cambronero F, Caro C, Pascual-Figal DA, Garrido IP, Pinar E, Valdés M, Lip GYH.
    Chest; 2008 Sep; 134(3):559-567. PubMed ID: 18641090
    [Abstract] [Full Text] [Related]

  • 2. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
    Choi HI, Ahn JM, Kang SH, Lee PH, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Park DW, Park SJ.
    JACC Cardiovasc Interv; 2017 Jun 12; 10(11):1075-1085. PubMed ID: 28527773
    [Abstract] [Full Text] [Related]

  • 3. Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation.
    Gao F, Zhou YJ, Wang ZJ, Shen H, Liu XL, Nie B, Yan ZX, Yang SW, Jia de A, Yu M.
    Circ J; 2010 Apr 12; 74(4):701-8. PubMed ID: 20208381
    [Abstract] [Full Text] [Related]

  • 4. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M, Gislason GH, Olesen JB, Kristensen SL, Schjerning Olsen AM, Mikkelsen A, Christensen CB, Lip GY, Køber L, Torp-Pedersen C, Hansen ML.
    J Am Coll Cardiol; 2013 Sep 10; 62(11):981-9. PubMed ID: 23747760
    [Abstract] [Full Text] [Related]

  • 5. Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.
    Faza NN, Mentias A, Parashar A, Chaudhury P, Barakat AF, Agarwal S, Wayangankar S, Ellis SG, Murat Tuzcu E, Kapadia SR.
    Catheter Cardiovasc Interv; 2017 Feb 01; 89(2):E64-E74. PubMed ID: 27220088
    [Abstract] [Full Text] [Related]

  • 6. Early and late outcomes of clopidogrel and coumadin combination for patients on oral anticoagulants undergoing coronary stenting.
    Ait Mokhtar O, Bonello L, Armero S, Sbragia P, Paganelli F.
    Cardiovasc Revasc Med; 2010 Feb 01; 11(3):159-62. PubMed ID: 20599166
    [Abstract] [Full Text] [Related]

  • 7. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    Kang DO, Yu CW, Kim HD, Cho JY, Joo HJ, Choi RK, Park JS, Lee HJ, Kim JS, Park JH, Hong SJ, Lim DS.
    Coron Artery Dis; 2015 Aug 01; 26(5):372-80. PubMed ID: 25768244
    [Abstract] [Full Text] [Related]

  • 8. Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry).
    Mennuni MG, Halperin JL, Bansilal S, Schoos MM, Theodoropoulos KN, Meelu OA, Sartori S, Giacoppo D, Bernelli C, Moreno PR, Krishnan P, Baber U, Lucarelli C, Dangas GD, Sharma SK, Kini AS, Tamburino C, Chieffo A, Colombo A, Presbitero P, Mehran R.
    Am J Cardiol; 2015 Jul 01; 116(1):37-42. PubMed ID: 25956624
    [Abstract] [Full Text] [Related]

  • 9. Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
    Smith JG, Wieloch M, Koul S, Braun OÖ, Lumsden J, Rydell E, Ohman J, Scherstén F, Svensson PJ, van der Pals J.
    EuroIntervention; 2012 Oct 01; 8(6):672-8. PubMed ID: 23086784
    [Abstract] [Full Text] [Related]

  • 10. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A.
    Pharmacotherapy; 2007 May 01; 27(5):691-6. PubMed ID: 17461704
    [Abstract] [Full Text] [Related]

  • 11. Outcome of patients on oral anticoagulation undergoing coronary artery stenting: data from discharge to 12 months in the Warfarin and Coronary Stenting (WAR-STENT) Registry.
    Rubboli A, Saia F, Sciahbasi A, Bacchi-Reggiani ML, Steffanon L, Briguori C, Calabrò P, Palmieri C, Rizzi A, Imperadore F, Sangiorgi GM, Valgimigli M, Carosio G, Steffenino G, Galvani M, Di Pasquale G, La Vecchia L, Maggioni AP, Bolognese L, WARfarin and Coronary STENTing (WAR-STENT) Study Group.
    J Invasive Cardiol; 2014 Nov 01; 26(11):563-9. PubMed ID: 25363997
    [Abstract] [Full Text] [Related]

  • 12. Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies.
    Barbieri L, Verdoia M, Schaffer A, Suryapranata H, De Luca G.
    Cardiovasc Drugs Ther; 2016 Dec 01; 30(6):611-622. PubMed ID: 27757726
    [Abstract] [Full Text] [Related]

  • 13. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
    Windecker S, Lopes RD, Massaro T, Jones-Burton C, Granger CB, Aronson R, Heizer G, Goodman SG, Darius H, Jones WS, Aschermann M, Brieger D, Cura F, Engstrøm T, Fridrich V, Halvorsen S, Huber K, Kang HJ, Leiva-Pons JL, Lewis BS, Malaga G, Meneveau N, Merkely B, Milicic D, Morais J, Potpara TS, Raev D, Sabaté M, de Waha-Thiele S, Welsh RC, Xavier D, Mehran R, Alexander JH, AUGUSTUS Investigators.
    Circulation; 2019 Dec 03; 140(23):1921-1932. PubMed ID: 31557056
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of aspirin, clopidogrel, and warfarin after coronary artery stenting in Korean patients with atrial fibrillation.
    Suh SY, Kang WC, Oh PC, Choi H, Moon CI, Lee K, Han SH, Ahn T, Choi IS, Shin EK.
    Heart Vessels; 2014 Sep 03; 29(5):578-83. PubMed ID: 23974943
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.
    Feldman DN, Minutello RM, Bergman G, Moussa I, Wong SC.
    Catheter Cardiovasc Interv; 2010 Oct 01; 76(4):513-24. PubMed ID: 20882655
    [Abstract] [Full Text] [Related]

  • 16. Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Popma JJ, Berger P, Ohman EM, Harrington RA, Grines C, Weitz JI.
    Chest; 2004 Sep 01; 126(3 Suppl):576S-599S. PubMed ID: 15383485
    [Abstract] [Full Text] [Related]

  • 17. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
    Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, Ten Berg JM, Steg PG, Hohnloser SH, RE-DUAL PCI Steering Committee and Investigators.
    N Engl J Med; 2017 Oct 19; 377(16):1513-1524. PubMed ID: 28844193
    [Abstract] [Full Text] [Related]

  • 18. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM, Marín F, Hurtado JA, Valencia J, Pinar E, Pineda J, Gimeno JR, Sogorb F, Valdés M, Lip GY.
    J Am Coll Cardiol; 2008 Feb 26; 51(8):818-25. PubMed ID: 18294566
    [Abstract] [Full Text] [Related]

  • 19. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD, Rao M, Simon DN, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Go AS, Hylek EM, Kowey P, Piccini JP, Singer DE, Chang P, Peterson ED, Mahaffey KW.
    Am J Med; 2016 Jun 26; 129(6):592-599.e1. PubMed ID: 26797080
    [Abstract] [Full Text] [Related]

  • 20. Rationale and design of MANJUSRI trial: a randomized, open-label, active-controlled multicenter study to evaluate the safety of combined therapy with ticagrelor and warfarin in AF subjects after PCI-eS.
    Lu W, Chen L, Wang Y, Yao Y, Fu C, Zuo P, Ma G.
    Contemp Clin Trials; 2015 Jan 26; 40():166-71. PubMed ID: 25513965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.